KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

References

• GieseABjerkvigRBerensMEWestphalMCost of migration: invasion of malignant gliomas and implications for treatmentJ Clin Oncol20032181624163612697889
   PubMed Web of Science ®Google Scholar
• LowensteinPRCastroMGThe long and winding road: from the high-affinity choline uptake site to clinical trials for malignant brain tumorsAdv Pharmacol20167614717327288077
   PubMedGoogle Scholar
• StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
   PubMed Web of Science ®Google Scholar
• MirimanoffROHigh-grade gliomas: reality and hopesChin J Cancer20143311324384235
   PubMedGoogle Scholar
• QiuZKShenDChenYSEnhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cellsChin J Cancer201433211512223958055
   PubMedGoogle Scholar
• MartinCZhangYThe diverse functions of histone lysine methylationNat Rev Mol Cell Biol200561183884916261189
   PubMed Web of Science ®Google Scholar
• KouzaridesTChromatin modifications and their functionCell2007128469370517320507
   PubMed Web of Science ®Google Scholar
• TsukadaYFangJErdjument-BromageHHistone demethylation by a family of JmjC domain-containing proteinsNature2006439707881181616362057
   PubMed Web of Science ®Google Scholar
• KottakisFFoltopoulouPSanidasINDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cellsCancer Res201474143935394624853546
   PubMed Web of Science ®Google Scholar
• HeJNguyenATZhangYKDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemiaBlood2011117143869388021310926
   PubMed Web of Science ®Google Scholar
• PfauRTzatsosAKampranisSCSerebrennikovaOBBearSETsichlisPNMembers of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent processProc Natl Acad Sci U S A200810561907191218250326
   PubMed Web of Science ®Google Scholar
• UedaTNagamachiATakuboKFbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2Blood2015125223437344625872778
   PubMed Web of Science ®Google Scholar
• TzatsosAPaskalevaPFerrariFKDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programsJ Clin Invest2013123272773923321669
   PubMed Web of Science ®Google Scholar
• ZhaoETangCJiangXInhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cellsCell Signal20173622222928506929
   PubMed Web of Science ®Google Scholar
• PasqualucciLTrifonovVFabbriGAnalysis of the coding genome of diffuse large B-cell lymphomaNat Genet201143983083721804550
   PubMed Web of Science ®Google Scholar
• TzatsosAPaskalevaPLymperiSLysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cellsJ Biol Chem201128638330613306921757686
   PubMed Web of Science ®Google Scholar
• TzatsosAPfauRKampranisSCTsichlisPNNdy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locusProc Natl Acad Sci U S A200910682641264619202064
   PubMed Web of Science ®Google Scholar
• TsangDPChengASEpigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2J Gastroenterol Hepatol20112611927
   PubMed Web of Science ®Google Scholar
• HuangBYPanXYLiZXWangZCYuYSDouZHPolycomb group proteins and their roles in regulating stem cell developmentZhongguo Yi Xue Ke Xue Yuan Xue Bao201234328128522776663
   PubMedGoogle Scholar
• MellingNThomsenETsourlakisMCOverexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersCarcinogenesis201536111333134026392259
   PubMed Web of Science ®Google Scholar
• GuoSLiXRohrJEZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic featuresDiagn Pathol2016114127113214
   PubMed Web of Science ®Google Scholar
• YangFLvLZCaiQCJiangYPotential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3BWorld J Gastroenterol20152147132681327626715809
   PubMed Web of Science ®Google Scholar
• EskanderRNJiTHuynhBWardehRRandallLMHoangBInhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell linesInt J Gynecol Cancer2013236997100523792601
   PubMed Web of Science ®Google Scholar
• SunMLiuXHLuKHEZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transitionCell Death Dis20145e129824967960
   PubMed Web of Science ®Google Scholar
• SmitsMNilssonJMirSEmiR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesisOncotarget20101871072021321380
   PubMedGoogle Scholar
• SuvaMLRiggiNJaniszewskaMEZH2 is essential for glioblastoma cancer stem cell maintenanceCancer Res200969249211921819934320
   PubMed Web of Science ®Google Scholar
• KottakisFPolytarchouCFoltopoulouPSanidasIKampranisSCTsichlisPNFGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathwayMol Cell201143228529821777817
   PubMed Web of Science ®Google Scholar
• KurtICSurIKayaEKDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAILCell Death Dis201786e289728661478
   PubMed Web of Science ®Google Scholar
• YuXWangJWuJShiYA systematic study of the cellular metabolic regulation of Jhdm1b in tumor cellsMol Biosyst20151171867187525877602
   PubMedGoogle Scholar
• OuyangQXuLCuiHXuMYiLMicroRNAs and cell cycle of malignant gliomaInt J Neurosci201612611926000816
   PubMed Web of Science ®Google Scholar
• ChangYCChouFPHuangHPHsuJDWangCJInhibition of cell cycle progression by penta-acetyl geniposide in rat C6 glioma cellsToxicol Appl Pharmacol20041981112015207644
   PubMed Web of Science ®Google Scholar
• IgataMMotoshimaHTsuruzoeKAdenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progressionCirc Res200597883784416151020
   PubMed Web of Science ®Google Scholar
• Lamba SainiMWeynandBRahierJMouradMHamoirMMarbaixECyclin D1 in well differentiated thyroid tumour of uncertain malignant potentialDiagn Pathol2015103225907675
   PubMed Web of Science ®Google Scholar
• ChangCJHungMCThe role of EZH2 in tumour progressionBr J Cancer2012106224324722187039
   PubMed Web of Science ®Google Scholar
• OrzanFPellegattaSPolianiPLEnhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cellsNeuropathol Appl Neurobiol201137438139420946108
   PubMed Web of Science ®Google Scholar
• AhaniNShirkoohiRRokoueiMAlipour EskandaniMNikraveshAOverexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissuesMed Oncol2014311125225294424
   PubMed Web of Science ®Google Scholar
• KimSHJoshiKEzhilarasanREZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent mannerStem Cell Reports20154222623825601206
   PubMed Web of Science ®Google Scholar
• LiAMDunhamCTaboriUEZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium studyCancer201512191499150725586788
   PubMed Web of Science ®Google Scholar
• LinLZhengYTuYMicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2Hum Pathol201546797198025907866
   PubMed Web of Science ®Google Scholar
• SharmaVPurkaitSTakkarSAnalysis of EZH2: micro-RNA network in low and high grade astrocytic tumorsBrain Tumor Pathol201633211712826746204
   PubMed Web of Science ®Google Scholar
• KimEKimMWooDHPhosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cellsCancer Cell201323683985223684459
   PubMed Web of Science ®Google Scholar
• KaroopongseEYeungCByonJThe KDM2B-let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapyPLoS One201499e10781725225797
   PubMed Web of Science ®Google Scholar
• WenYCaiJHouYHuangZWangZRole of EZH2 in cancer stem cells: from biological insight to a therapeutic targetOncotarget2017823379743799028415635
   PubMedGoogle Scholar
• ZhangYYuXChenLZhangZFengSEZH2 overexpression is associated with poor prognosis in patients with gliomaOncotarget20178156557327880940
   PubMedGoogle Scholar